Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
12
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution12 total trials
N/ANon-phased studies
12(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

10 of 10 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(10)
Other(2)

Detailed Status

Completed10
unknown2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A12 (100.0%)

Trials by Status

completed1083%
unknown217%

Recent Activity

Clinical Trials (12)

Showing 12 of 12 trials
NCT04853797Not Applicable

Effect of Ivabradine on Levcromakalim-Induced Symptoms in Individuals With Migraine Without Aura (ILIM)

Completed
NCT05211050Not Applicable

Effect of Sumatriptan on Levcromakalim-Induced Symptoms in Individuals With Migraine

Completed
NCT05889442Not Applicable

Effect of Levcromakalim in Individuals With Migraine Pretreated With Erenumab

Completed
NCT05093582Not Applicable

The Effects of Levcromakalim in Patients With Cluster Headache

Completed
NCT04905654Not Applicable

Migraine Inducing Effect of Levcromakalim in Patients With Migraine With Aura

Completed
NCT05565001Not Applicable

The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain.

Unknown
NCT05243953Not Applicable

Hypersensitivity to Opening of ATP-Sensitive Potassium Channels in Post-Traumatic Headache

Completed
NCT03886922Not Applicable

The Hemodynamics Effect of Glibenclamide on Levcromakalim Assessed by High Resolution Magnetic Resonance Angiography (MRA) Technique in a Randomized Double-blind Cross-over Placebo-controlled Study With Healthy Volunteers

Unknown
NCT03609008Not Applicable

The Effect of Levcromakalim Infusion on the Cranial Arteries Over Several Hours Using a High Resolution MRA Technique in a Randomized, Double-blind Placebo-controlled Design in Healthy Volunteers.

Completed
NCT04012047Not Applicable

Headache Inducing Effect of Levcromakalim in Migraine With Aura Patients

Completed
NCT03726242Not Applicable

Peripheral Nociceptive Effects of Levcromakalim

Completed
NCT03228355Not Applicable

Headache Inducing Effect of Cromakalim in Migraine Patients

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12